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Abstract 
The cellular landscape of the human intestinal tract is dynamic throughout life, developing in 
utero and changing in response to functional requirements and environmental exposures.  
To comprehensively map cell lineages in the healthy developing, pediatric and adult human 
gut from ten distinct anatomical regions, as well as draining lymph nodes, we used single-
cell RNA-seq and VDJ analysis of roughly one third of a million cells. This reveals the 
presence of BEST4+ absorptive cells throughout the human intestinal tract, demonstrating 
the existence of this cell type beyond the colon for the first time. Furthermore, we implicate 
IgG sensing as a novel function of intestinal tuft cells, and link these cells to the 
pathogenesis of inflammatory bowel disease.  We define novel glial and neuronal cell 
populations in the developing enteric nervous system, and predict cell-type specific 
expression of Hirschsprung’s disease-associated genes. Finally, using a systems approach, 
we identify key cell players across multiple cell lineages driving secondary lymphoid tissue 
formation in early human development. We show that these programs are adopted in 
inflammatory bowel disease to recruit and retain immune cells at the site of inflammation. 
These data provide an unprecedented catalogue of intestinal cells, and new insights into 
cellular programs in development, homeostasis and disease.  
 
Introduction 
Intestinal tract physiology relies on the integrated contribution of epithelial, mesenchymal, 
endothelial, mesothelial, innate and adaptive immune, and neuronal cell lineages, whose 
relative abundance and cell networking fluctuate from embryonic development to adulthood. 
Factors contributing to these dynamics include gut function, environmental challenges and 
disease states that vary at different life stages. Adding further complexity is that the intestinal 
tract is formed of distinct anatomical regions that develop at different rates and carry out 
diverse roles in digestion, nutrient absorption, metabolism, and immune regulation in 
adulthood.  
 
Single-cell analyses of intestinal organoids from iPSCs and human primary tissue have 
provided a unique opportunity to study the earliest stages of gut development. Although 
focused mainly on epithelial cells, they have led to identification of factors driving cellular 
differentiation 1,2 and novel markers of rare cell types 3. Analysis of rare fetal intestinal 
tissues have further resolved the formation of villi-crypt structures and seeding of immune 
cells into the gut environment 4,5.  
 
Similarly, our understanding of the cellular landscape of the adult gut is benefiting from 
single-cell technologies. We have previously reported regional differences in immune cell 
activation in the healthy human colon linked to variability in the microbiome composition 6 
and expression of ligand-receptor pairs between cell populations has been used to infer 
cellular communication involving enteric neuronal cells subtypes 7. Studies comparing 
inflammatory bowel disease (IBD) samples to healthy controls or non-inflamed tissue have 
allowed for the identification of a new stromal subtype that expands in disease 89, clonal 
expansion of tissue-resident CD8 T cells in disease 10–12 and correlation between cellular 
response and clinical treatment 13. While extensive work has been carried out to profile the 
intestinal tract at single-cell resolution, a holistic analysis of the gut through space 
(anatomical location) and time (lifespan) is lacking.  
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Here, we create a broad and deep single-cell census of the healthy human gut, 
encompassing around 350,000 cells from 11 distinct anatomical sites during embryonic and 
fetal development, childhood and adulthood. In doing so, we reveal new insights into the 
epithelial compartment: we identify the presence of BEST4+ enterocytes in both small and 
large intestine and throughout life, and define a role for IgG sensing by tuft cells in IBD. In 
the developing enteric nervous system, we identify multiple novel populations, and highlight 
cell communication networks with stromal cells via receptors and ligands associated with 
Hirschsprung’s disease. In addition, we identify key cells and signaling networks initiating 
lymphoid structure formation in early human development. Interestingly, the same 
developmental programmes are adopted to drive recruitment of immune cells during 
pediatric Crohn’s disease. Thus our high-resolution genomic definition of human cells and 
gene expression programmes across epithelial, enteric nervous system and immune 




Integrated view of human gut throughout life 
To investigate cellular profiles and communication networks across the intestinal tract, we 
performed scRNA-seq on distinct tissue regions of the second-trimester (12-17 post-
conception weeks (PCW)) fetal and adult (29-69 years) intestine and draining mesenteric 
lymph nodes (mLN) (Figure 1A & Supplementary Fig. 1A). In adult samples, immune 
(CD45+) and non-immune (CD45-) cells were separated and loaded for scRNA-seq in 
equivalent proportions. To represent the gut at embryonic and early postnatal life, we 
incorporated our previously published embryonic (6-10 PCW; small intestine, large intestine) 
and pediatric (4-12 years; ileal) scRNA-seq data 4.  
 
After quality control and doublet removal, the combined dataset comprised over 346,000 
intestinal cells (Supplementary Fig. 1B). Leiden clustering and marker gene analysis 
revealed major clusters of epithelial, mesenchymal, endothelial, lymphocytes, neuronal, 
myeloid and erythroid cells (Fig. 1B). Fetal gut samples were enriched for mesenchymal 
cells and relatively high numbers of neuronal cells, with increased abundance of immune cell 
types from the second trimester onwards (Figure 1C & Supplementary Fig. 2A). Mesenteric 
lymph nodes, collected from second-trimester onwards, predominantly contained immune 
cells (Figure 1C & Supplementary Fig. 2A). Further sub-clustering of the cellular populations 
allowed for identification of 103 cell types and states with specific transcriptional identities 
(Supplementary Fig. 1B & 2B). 
 
Notably, BEST4+ enterocytes, recently described in the human colon and predicted to 
transport metal ions and salts 9,14, were identifiable in all regions of the fetal and adult 
intestinal tract suggesting a requirement for these functions in small and large intestines 
throughout life (Figure 1D-E). Adult small intestinal BEST4+ cells formed a distinct cluster, 
separated from adult large intestinal and fetal BEST4+ cells (Supplementary Fig. 2C). Using 
a novel differential cell-type abundance analysis method called “Milo” (Methods), we 
identified expression signatures specific to small intestinal BEST4+ cells, including adhesion 
G protein-coupled receptor ADGRG4 and cadherin CDH23 (Figure 1F, Supplementary Fig. 
2D-E). BEST4+ enterocytes of the adult large intestines expressed higher levels of OTOP2 
(Figure 1F), suggesting a greater propensity for proton transport. While small and large 
intestine shared expression of the carbonic anhydrase CA7, CA4 was more highly 
.CC-BY-NC-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint (whichthis version posted April 7, 2021. ; https://doi.org/10.1101/2021.04.07.438755doi: bioRxiv preprint 
 
expressed in the large intestines. Interestingly, small intestinal BEST4+ cells were marked 
by high expression of chloride channel and cystic fibrosis gene CFTR (Figure 1F), which we 
also observed at the protein level (Supplementary Fig. 2F). Over 60% of cystic fibrosis 
patients experience intestinal symptoms characterised by inflammation and sticky mucus 15. 
This analysis elucidates distinctions between subtypes of BEST4+ epithelial cells found 
along the intestinal tract, and specifically implicates small intestinal BEST4+ cells in cystic 
fibrosis pathogenesis. 
 
Together, this represents an in-depth cell census of the gut and a map of cellular diversity 
across regions and developmental time. This dataset enables us to determine previously 
unappreciated patterning of gene expression in the BEST4+ enterocyte compartment along 
the intestine.  
 
Diversity of epithelial cells in the human intestinal tract 
Next, we further investigated the composition of the prenatal and postnatal gut epithelium in 
detail. This lineage is formed of major classes of absorptive cells, secretory and 
enteroendocrine cells (EECs) (Figure 2A, Supplementary Fig. 2B & 3A). The absorptive cells 
separate into clusters of pediatric and adult small intestinal enterocytes, and large intestinal 
colonocytes in the pediatric and adult samples. The secretory cells include goblet, tuft, 
paneth and microfold (M) cells, as well as the precursor states. 
 
Focused subclustering of EECs revealed TPRH1+, NEUROG3-high, NTS/GCG/PYY+, 
MLN/GHR+, CCK+ and GAST/GIP+ subsets (Figure 2A & Supplementary Fig. 2B), 
resembling populations recently described in intestinal organoid experiments 2. Comparing 
the cellular composition of the epithelium across age groups highlighted a drastic 
developmental shift at approximately 10 PCW, with a majority of undifferentiated epithelial 
cells prior to this point (Figure 2B & Supplementary Fig. 3B). NEUROG+ EECs were 
enriched in the first trimester fetal gut, while NTS/GCG/PYY+ EECs and MLN/GHRL+ EECs 
were only evident from the second trimester through to adulthood (Figure 2B & 
Supplementary Fig. 3B). NEUROG3, a transcription factor that mediates epithelial cell 
commitment to EEC lineage 16, and the absence of mature neuropeptides suggests that the 
NEUROG3+ EECs may represent early committed EECs.  
 
M cells, which specialise in transferring luminal antigen through the epithelial lining of the gut 
were very rare and seen only in pediatric and fetal samples within this dataset (Figure 2B & 
Supplementary Fig. 3B). Interestingly, expression of MHCII was restricted to postnatal cells 
(Supplementary Fig. 3C), suggesting that this expression is driven by the presence of the 
microbiome. All mature epithelial cell types were present from 12 PCW, except paneth cells, 
which appeared postnatally (Figure 2B & Supplementary Fig. 3B).  
 
The gut epithelium represents a point of viral entry, and SARS-CoV-2 has been shown to 
enter enterocytes via the receptor, ACE2, and protease, TMPRSS2 17. We used our 
developing gut epithelial dataset to investigate whether viral entry is possible at all life 
stages. Indeed, both ACE2 and TMPRSS2 were expressed by enterocytes in early 
development, childhood and adulthood, with TMPRSS2 also expressed by BEST4+ 
enterocytes and M cells (Figure 2C & Supplementary Fig. 3D). This highlights for the first 
time the ability for SARS-CoV-2 to infect the fetal gut epithelium.  
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IBD pathogenesis is due to impaired intestinal epithelial cell function (as well as exacerbated 
immune functions). We sought to investigate how IBD risk may be linked to cell types across 
the anatomical regions of the gut, by analysing expression of IBD-associated epithelial cell 
type marker genes. We focused on the pediatric and adult epithelial compartments, since 
IBD onset is most prevalent at later life stages. Expression of IBD-GWAS genes was largely 
consistent across regions, with most variability arising from the presence or absence of cells 
per region (Figure 2D). In particular, paneth cells present only in the small intestine during 
health and well documented as metaplastic in colon of IBD patients18, showed specific 
expression of intelectin, ITLN2, also previously shown to be enriched in the small intestine 19. 
Surprisingly, PLCG2, two missense variants of which have been linked to aberrant B cell 
responses in early onset IBD 20,21 and primary immune deficiency 22, was specifically 
expressed by tuft cells.  
 
To more deeply explore the relevance of PLCG2 expression in epithelial cells of IBD 
patients, we compared epithelial PLCG2 expression across different developmental stages 
and Crohn’s disease. We observed a small increase in expression of PLCG2 in Crohn’s 
disease epithelium (Supplementary Fig. 3E). To further confirm the role of epithelial PLCG2 
in inflammation, we stimulated primary tissue derived intestinal organoids with inflammatory 
cytokines TNF-alpha or IFN-gamma and performed scRNAseq. While there was no 
morphological difference in stimulated organoid lines (Supplementary Fig. 3F), we confirm 
an increase in PLCG2 expression across stimulated organoid epithelial cells (Supplementary 
Fig. 3G, n=3).   
 
The discovery of expression of PLCG2 by tuft cells at higher levels than B and myeloid cell 
lineages (Supplementary Fig. 3H-J) led us to wonder whether tuft cells specifically could be 
responsive to signals from immune cells. We therefore analysed the expression of genes 
involved in immune surveillance by these cells. We screened for expression of ITAM-linked 
receptors that may activate PLCG2 (Supplementary Fig. 3K). Among these, only FCGR2A, 
which is activated in response to IgG and shown to be expressed by epithelial cells in 
immunized mice 23, was specifically expressed by a fraction (2.75%) of tuft cells (Figure 2E). 
Using the mouse as a model, we confirmed expression of Fcgr3 (ortholog of FCGR2A) at 
protein level by approximately 5% of small intestinal tuft cells (Figure 2F & Supplementary 
Fig. 3L). Receptor tyrosine kinases were also expressed across tuft cells and other epithelial 
cell types, however since these are known to be mainly linked to PLCG1 activation, whether 
they are also responsible for PLCG2 activation in tuft cells is difficult to delineate (Figure 
2E,G & Supplementary Fig. 3J). 
   
Tuft cells are known to be receptive to chemical signals with essential roles in pathogen 
responses of the gut 24–27. Indeed we confirm expression of the succinate receptor, 
SUCNR1, and downstream mediators GNAT3, PLCB2, ITPR2, PRKCA and TRPM5 (Figure 
2E,G), which lead to IL-25-mediated type 2 immune responses. While mouse studies have 
also implicated TAS1R3 28, we additionally show expression of TAS1R1, albeit at a lower 
level.  TAS1R1 forms a heterodimer with TAS1R3 for umami sensing to activate the same 
type 2 immune signaling 26  (Figure 2E,G). 
 
Our in depth analysis of the gut epithelium adds resolution to its changing composition 
throughout life, showing regional patterning of IBD-GWAS genes in the adult gut and 
discovering the likely capacity of tuft cells to sense IgG through PLCG2 activation. This leads 
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us to hypothesize that PLCG2 genetic variants may block the receptiveness of tuft cells and 
inhibit their downstream signaling to other immune cells, thus contributing to increased risk  
of IBD.  
 
Enteric nervous system differentiation during development  
Similar to the epithelium, the enteric nervous system displayed a shift in development at 10-
12 PCW. This provided us the opportunity to investigate the differentiation of human Enteric 
Neural Crest Cell (ENCC) progenitors. ENCC progenitors are derived from vagal or sacral 
neural crest cells that colonise the gut during embryonic development. ENCCs must balance 
proliferation and differentiation into glia and neurons without depleting the precursor pool, as 
premature differentiation of ENCCs leads to aganglionic colon 29,30.  
 
Cycling ENCC progenitor cells, co-expressing RET, SOX10, EDNRB, were most evident in 
first-trimester development (Supplementary Fig. 4A, B). The remaining cycling populations 
(G2M stages) showed polarised expression of glial and neuronal genes (Figure 3A-B; 
Methods), suggestive of distinct proliferating committed progenitors. Both of these committed 
progenitor populations expressed genes distinct from those observed in differentiated cells 
of ENCC-lineage. For example, committed glial progenitors expressed high levels of ASPM 
and SGO2 (Supplementary Fig. 4C). Amongst genes expressed by neuronal committed 
progenitors were GDF10, which acts through TGFβ signalling to activate axon sprouting 31, 
multiple Notch ligands (DLL1, DDL3) and Notch enhancer MFNG, altogether implicating 
NOTCH and TGFβ signalling in human neuroblast differentiation (Supplementary Fig. 4C). 
The developmental transition from ENCC progenitor to glial or neuronal progenitors towards 
terminal cell types was supported by trajectory analysis (Figure 3C, Supplementary Fig. 4D-
F).  
 
While ENCCs were abundant in the first-trimester, differentiated neuronal and glial cell types 
were enriched in the second-trimester of development (Supplementary Fig. 4B). All terminal 
glial cells expressed high levels of neural crest precursor genes including FOXD3, MPZ, 
CDH19, PLP1, SOX10, S100B and ERBB3, but lacked RET (Supplementary Fig. 4C). We 
further defined enteric glia (marked by BCAN, APOE, CALCA, HES5, FRZB), and three 
subsets of Schwann cell precursor (SCPs) all marked by PLP1, PMP22, CDH19, ITGA4 and 
CDH2, but varying in expression of TFAP2A, DHH and FABP7 (BFABP) (Figure 4C). All 
three subsets lacked expression of POU3F1 (OCT6), but highly expressed CDH19, a marker 
restricted to SCPs 32, supporting their identity as precursors rather than mature Schwann 
cells. In particular, the first subset, which we labelled ‘SCP’, was enriched in the first-
trimester and marked by specific expression of TFAP2B and CXCL13. Both transcription 
factor TFAP2A (AP-2α) and its paralog TFAP2B (AP-2β) have been shown to be expressed 
in SCPs, but not immature Schwann cells, and regulate timing of SCP differentiation 33. The 
second subset, termed ‘Myelin Schwann-like’, highly expressed myelin associated genes 
(MGP, MBP, DHH, NTRK2, SBSPON), while the third subset, termed ‘Non-myelin Schwann-
like’, was enriched in TFAP2A, ELN, FABP7 and BMP8B expression (Figure 3C, 
Supplementary Fig. 3C). We visualised BMP8B+ Non-myelin Schwann-like cells in the 
myenteric plexus (Supplementary Fig. 4G), while DHH+ Myelin Schwann-like cells were 
found primarily in the mesentery (Figure 3D). SCPs give rise to 20% of enteric neurons with 
SCP-derived neurons emerging postnatally in mice 34. Consistent with this observation, we 
did not observe differentiation of SCPs into neuronal subsets during embryonic and fetal 
development in humans (Figure 3C, Supplementary Fig. 4D-F). 
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Neuronal differentiation extended from neuroblasts into two main neuronal branches, and 
one additional sub-branch (Figure 3C). Both main branches were found in all intestinal 
regions (Supplementary Fig. 4H). The first branching event divided branch 1, expressing 
BNC2 and RAMP1, from branch 2, expressing ETV1 and KCNJ5. Branch 2 further divided 
into sub-branches 2a and 2b, distinct in expression of gastrin releasing peptide GRP, 
transcription factor NEUROD6 in sub-branch 2a versus calcium binding protein SCGN, 
neurexophilin-2 NXPH2 and netrin-G1 NTNG1 in sub-branch 2b (Supplementary Fig. 4C). 
We visualise and validate the cells belonging to branch 1, 2a and 2b in the human myenteric 
plexus using smFISH in Figure 3E.  
 
We sought to relate developing neuron branches to mature enteric neuron subtypes 
(Supplementary Fig. 4J). Branch 1 neurons, in addition to BCN2, expressed TSHZ2, ALK 
and HTR4 reminiscent of putative excitatory motor neurons 7. Branch 2a neurons expressed 
genes for both putative inhibitory motor neurons (NOS1, GFRA1, PTGIR, KCNJ5, DGKB, 
and NPY) and putative secretomotor/vasodilator neuron markers (VIP, ETV1, SCGN, and 
UNC5B) 7, suggesting this branch gives rise to both types of neurons. Branch 2b highly 
expressed TAC1, PENK, BMPR1B, ADRA2A and NXPH2 reminiscent of putative 
interneurons 7. The developing branches expressed low levels of putative sensory neuron 
marker genes (CALCA, NMU, SST, DLX3), suggesting that this subtype develops later in 
gestation (Supplementary Fig. 4J).  
 
Cellular circuitry of Hirschsprung's disease  
Hirschsprung's disease is characterised by loss or impaired differentiation of the enteric 
nervous system and can manifest at variable locations of the distal bowel. To identify cell 
types involved in Hirschsprung’s disease, we screened ENCC-lineage cells for the 
expression of Hirschsprung’s disease-associated genes 35,36. We further included genes 
associated with Hirschsprung’s disease phenotype in mice37, but currently lacking clinical 
association in humans. 
 
The majority of Hirschsprung’s disease-associated genes were expressed across multiple 
differentiating populations with varying intensity (Supplementary Fig. 4I). For example, 
UBE2T was most highly expressed by committed proliferating progenitors, while other 
Hirschsprung’s disease-associated genes were highly expressed in glial (ZEB2, COMT, 
NTRK3) or neuronal (TLX2, SEMA3D, L1CAM, HOXB5) compartments (Supplementary Fig. 
4I). Expression levels of disease genes also varied between the three developing neuron 
clusters (branches 1, 2a and 2b). For example, ASCL1 was highly expressed in branch 1 
and 2a, but not in branch 2b. RET was selectively absent from branch 1, and GFRA2 absent 
from branch 2a.  
 
Interestingly, CDH2, L1CAM and RET were more highly expressed in colonic neuronal 
lineage cells compared to the equivalent cells in the small intestine, while the opposite was 
true for ATRX and ASCL1 (Supplementary Fig. 4I). We also observe unexpected expression 
of NTRK3 in pro-myelin SCPs (Supplementary Fig. 4I). Mice lacking Ntrk3 or its ligand Nt3 
have reduced numbers of intrinsic sensory neurons 38, suggesting that pro-myelin SCPs may 
support the differentiation of neurons during development.   
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To understand the contribution of mesenchymal cell subsets to pathogenesis of 
Hirschsprung’s disease, we investigated the expression of key Hirschsprung’s disease-
associated ligands and their receptors 35,36 across gut cells of all developmental ages (Figure 
3F). Among these ligands was GDNF that activates RET and its co-receptor GFRA1, EDN3 
and its receptor EDNRB3, and NRG1 and its receptor ERBB2. We observed expression of 
GDNF and EDN3 primarily by smooth muscle cells (SMC) and interstitial cells of Cajal (ICC) 
(described among stromal cells below; Figure 3F). While in adult gut NRG1 is expressed by 
glial and multiple neuron subtypes 39, in the fetal gut NRG1 was highly expressed in 
neuronal branch 2b. Its receptor ERBB2 was expressed across glial and stromal cells 
including ICC and SMC (Figure 3F,G). NRG1 acts as a neurotrophic factor and supports 
growth, proliferation and differentiation of the enteric nervous system. Our analysis 
implicates fetal branch 2b neurons, and ICC/SMC interactions, in the pathogenesis of 
Hirschsprung’s disease.  
 
Formation of secondary lymphoid structures 
The gut has its own elaborate nervous system as detailed above, and is also a unique organ 
with respect to having its own immune system. Secondary lymphoid structures (SLO) are 
key sites of immune surveillance and serve to initiate adaptive immune response to 
exogenous pathogens. Development of SLOs in the gut, including gut-associated lymphoid 
tissues (GALT) and mesenteric lymph nodes (mLN), has been reported to begin between 8 
to 12 PCW in humans 40. We observed mLNs starting around 12 PCW, with structures 
clearly recognisable and disectable at 15 PCW (Supplementary Fig. 5A). In order to better 
understand the fetal gut-resident immune cells and their organisation in humans, we 
investigate in detail the key cell types involved in lymphoid tissue organisation during 
embryonic development.  
 
Lymphoid tissue inducer (LTi) cells, categorised as group 3 innate lymphoid cells (ILC3), 
interact with lymphoid tissue organiser (LTo) cells to initiate SLO formation during 
development in mice and humans41. Sub-clustering of fetal and adult T and innate lymphoid 
cells revealed three cell clusters matching published characteristics of LTi cells (Figure 
4A,B). These characteristics include high expression of RORC, KIT, NRP1, TNF, LTA/B, 
IL7R, and ITGB7 (integrin α4β7) (Figure 4A,C) as well as the absence of productive αβ TCR 
chains (Supplementary Fig. 5B). The cluster labelled  innate lymphoid cell progenitor (ILCP) 
was further defined by high expression of chemokine receptors CXCR5 and CCR7, and high 
expression of cell adhesion molecule SCN1B 42 and serine protease encoded by HPN gene 
(Figure 4C). The second cluster labelled ‘LTi-like ILC3’ clustered closely with adult ILC3 cells 
and had the highest expression of TNFRSF11A (RANK) and its ligand TNFSF11 (RANKL), 
as well as NCR1 (NKp46) and NCR2 (NKp44) supporting an ILC3 phenotype for this cell 
population (Figure 4C). Both ILCP and LTi-like ILC3 cells expressed high levels of NRP1, 
previously shown to mark human ILC3 cells with LTi cell function 43.  
 
Lastly, a third population, which we term ‘LTi-like NK/T’, express IL17A, ITGAE and CCR9, 
and NK-associated genes including NKG7, PRF1, and GZMA, but lack expression of 
CXCR5. While we did not capture productive TCRαβ chains in this population, we observed 
expression of CD3 genes (CD3G, CD3D and CD3E) and TCRδ genes (TRDC, TRDV2), 
suggesting they are үδ T cells (Figure 4C, Supplementary Fig. 5B). Reassuringly, these 
three LTi-like cell subtypes were also identifiable in our full-length scRNAseq data from fetal 
ileum cells (Supplementary Fig. 5D).  
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ILCP cells were enriched at 6-10 PCW, while LTi-like ILC3 and LTi-like NK/T cells were 
present at 6-17 PCW (Figure 4C) and expanded in all gut regions throughout development 
(Supplementary Fig. 5E). Only ILCP cells were captured in fetal mLN (Supplementary Fig. 
5E), suggesting that LTi-like subsets are expanded during GALT, but not mLN development. 
This observation together with expression of key chemokine signals (CXCR5, CCR7, CCR6) 
and RNA velocity analysis suggested that ILCP cells are the first LTi-like cells in the 
developing gut. Hence they likely represent a progenitor state to mature ILC3s (Figure 4C, 
Supplementary Fig. 5F). RNA smFISH staining placed CXCR5+ RORC+ ILCP/LTi-like ILC3 
cells in proximity to CXCL13+ LTo cells in fetal proximal gut mucosa, supporting the concept 
of congregation of these cells beneath the epithelium in the developing gut (Figure 4D). 
 
In order to infer whether the developing lymphoid structures were partitioned into B and T 
cells zones as evident in mature lymphoid tissue, we characterised B cells in fetal and adult 
tissues. During fetal development, common lymphoid precursor (CLP) cells (CD34, FLT3, 
SPINK2), Pro-B (DNTT, VPREB1/3, IGLL1, RAG1/2), Pre-B (CD19, CD38, IGLL5, RAG1/2) 
and immature B cells (CD40, productive IgM, MHC II) were evident (Supplementary Fig. 6A-
E). In the adult gut, we detected light zone (EBI3, LMO2, GMDS and BCL2A1) and dark 
zone (AICDA, SUGCT, EZR and ISG20) germinal centre B cells enriched in the pediatric 
terminal ileum. This supports the presence of fully mature and organised lymphoid 
aggregates in the adult but not fetal tissue (Supplementary Fig. 2B, 6F-G).  
 
Analysis of paired V(D)J sequencing data revealed almost exclusive IgM heavy chain 
expression across all fetal gut B cells and no evidence for meaningful levels of clonal 
expansion and somatic mutation. In comparison, adult B cells expressed primarily IgA1 and 
IgA2 with minor populations of IgM, IgG1 and IgG2 cells, fitting with our previous report 6, 
and displayed high mutational frequency and clonal expansion consistent with having 
undergone affinity maturation (Supplementary Fig. 6H-I). Mutation frequency and clonal 
expansion were slightly higher at the proximal and distal ends of the adult gut, and sharing of 
B cell clones, while restricted to occurring within each donor, was evident across distant gut 
regions (Supplementary Fig. 6J-L). These results suggest zonation of B cells within postnatal 
gut mucosa, in addition to antigen activation, class-switching of B cells and dissemination of 
B cell clones between small and large intestine.  
 
In contrast to adult B cells, we found no evidence of fetal B cell expansion or maturation in 
response to antigen. This suggests that additional environmental factors, such as microbiota, 
might be required for the maturation and zonation of B cells in secondary lymphoid organs. 
Taken together, our data identifies three types of LTi cells orchestrating the earliest 
development of lymphoid structures, and B cells that are poised for response in these sites 
in the prenatal intestine. 
 
Stromal cells in human mLN and GALT development  
LTo cells are LTβR+ non-hematopoietic cells that interact with LTi cells during lymph node 
formation, and can be either mesenchymal (mLTo) or endothelial (eLTo) in origin. LTi and 
LTo cell interaction leads to activation of canonical and non-canonical NF-κB pathways, and 
results in LTo secretion of chemokines CCL19, CCL21 and CXCL13 as well as expression of 
adhesion molecules VCAM-1, ICAM-1 and MAdCAM-1. After visualising RORC+ CXCR5+ 
LTi-like ILCP/ILC3 cells in proximity to CXCL13+ cells in fetal gut mucosa as mentioned 
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above (Figure 4D), we postulate that GALT formation follows similar mechanisms to those 
previously described in the mLN. To address this, we analyse stromal populations from both 
gut tissue and mLN.  
 
Within the entire dataset, we identify multiple stromal populations defined by the expression 
of VIM, COL1A2 and COL6A1 (Supplementary Fig. 2B) including myofibroblasts, smooth 
muscle cells (SMC, SMC1), pericytes, ICCs, mesothelium, as well as populations resembling 
stromal cells previously described in the colon (labelled as S1-S4) 8 (Figure 5A). We further 
identified fibroblast populations typically defined in mouse lymph nodes 44, including T 
reticular cells (expressing CCL21, CCL19 and GREM1) and follicular dendritic cells (FDCs; 
expressing CXCL13, CR1 and CR2) (Supplementary Fig. 7A). T reticular cells and FDCs 
were found in the terminal ileum (Supplementary Fig. 7B). These samples were also 
enriched for LZ and DZ GC B cells (Supplementary Fig. 2B, 6F-G), suggesting the presence 
of cells that organise Peyer's patches.  
 
In prenatal intestine (12-17 PCW) and mLN, we observe a stromal cell population 
transcriptionally similar to T reticular, FDCs and S4 fibroblasts (Figure 5A subpanel, 5B & 
Supp. Figure 7C). This stromal cell cluster, absent from pediatric and adult samples, was 
marked by expression of chemokines CCL19, CCL21 and CXCL13 as well as adhesion 
molecules (Figure 5C), and resembles activated mLTo cells described in developing mouse 
lymph nodes 45. Other genes expressed in mLTo cells were components of the NF-κB 
pathway (NFKBIA, NFKB1/2, IL32, REL, RELA/B), S1P transporter spinster homolog 2 
SPNS2, involved in T and B cell trafficking 46 and chemokines CXCL2 and CXCL3 
(Supplementary Fig. 7D).  
 
We further investigate the transcriptional differences of mLTo cells from lymph nodes and 
intestinal regions to define differences that could lead to differential positioning of SLOs. 
Interestingly, large intestinal mLTo cells share transcriptional characteristics with mLN mLTo 
cells, including expression of C7 and SLC22A3 (Supplementary Fig. 7E), suggesting 
similarities between mLN and cryptopatch development. Amongst the genes highly 
expressed in mLN mLTo cells were angiotensin receptor APLNR, endothelin receptor 
EDNRA and extracellular matrix protein TNC, all with roles in blood vessel formation. In 
addition, mLTo cells in mLNs expressed IL33 and FDCSP, also present in lymph node and 
spleen fibroblastic reticular cells 47 and observed in fibroblasts expanded in ulcerative colitis 
8. Thus, transcriptionally similar mLTo cells are implicated in the formation of human GALT 
as well as mLN tissue development.  
 
Endothelial cells in mLN and GALT organisation 
As lymphatic endothelial cells (LECs) connect the mLN to the tissue and can contribute to 
SLO formation by interacting with LTi and mLTo cells, we investigated endothelial cell 
heterogeneity. Amongst endothelial cells we observe arterial, venous, capillary and 
lymphatic endothelial cells (Supplementary Fig. 2B, 7F-G). LECs separated into six clusters 
(labelled LEC1-6), all uniformly expressing PROX1 and LYVE1, and TNFRSF11A (RANK), 
IL7 and CCL21- signals required for initial recruitment of LTi cells (Figure 5D; Supplementary 
Fig. 7H,I). LEC1 and LEC5 ressemble subsets described in human lymph nodes 48. The 
LEC1 subset is marked by specific expression of C7, TMEM100 and abundant expression of 
ACKR4 and CAV1, resembling cells lining the subcapsular sinus ceiling in the human lymph 
nodes 48, while LEC5 express CLDN11, ANGPT2 and GJA4, shown to be expressed on 
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collecting lymphatic valves (Supp. Figure 7I)48. We further define LEC3 present mostly in the 
pediatric and adult intestinal regions, and LEC4 specific to developing intestinal regions 
(Supplementary Fig. 7J), which may represent developing and differentiated lymphatic 
vessels present in the intestinal mucosa.   
 
LEC2 cells emerge during the second trimester (15-17 PCW) and are present in gut regions 
as well as fetal mLNs (Supp. Figure 7J). This population expresses TNFRSF9, THY1, 
CXCL5, and CCL20, similarly to a population of LECs lining the subcapsular sinus floor in 
human lymph nodes (Supp. Figure 7I)48. In addition, they express genes ANO9, PSD3 as 
well as high levels of adhesion molecules including MADCAM1, VCAM1 and SELE, 
suggesting their involvement in lymphocyte recruitment (Figure 5D, Supplementary Fig. 7K). 
LEC6 was marked by expression of ADAMTS4, metallothionein genes such as MT1X, 
MT1E, and is enriched in the adult appendix and mLN (Supplementary Fig. 7I,J). Similarly to 
mLTo cells, LEC2 and LEC6 express targets of the canonical NFkB pathway 
(Supplementary Fig. 7L). As LEC2 is present during development, NFkB pathway activation 
suggests that the LEC2 population contributes to organisation of GALTs. Finally, histological 
staining of fetal ileum allows us to identify blood vessels resembling high endothelial venules 
(Figure 5E), which would permit entry of lymphocytes into the tissue.  
 
Mesenchymal and endothelial cells are central to the recruitment and positioning of 
leukocytes in developing and mature mLN and GALT structures. To determine cell-cell 
interactions governing early lymphoid structure formation and leukocyte recruiting, we 
investigate complementary ligand-receptor expression across LECs, mLTo and LTi-like 
subsets. Amongst ligand-receptors expressed were LTA and LTB (LTα1β2) expressed on all 
LTi-like cell subsets and LTBR (LTβR) on mLTo and multiple LEC subsets (Supplementary 
Fig. 8A), characteristic of LTo and LTi cells 41. Interestingly, we found that LTi-like ILC3 and 
NK/T cells utilise CD40LG to signal to mLTo and LEC through either CD40 or integrin a5b1 
(ITGA5), respectively (Supplementary Fig. 8A). The activation of this signalling pathway in 
endothelial cells has been previously reported to drive angiogenesis 49, suggesting that LTi-
LEC interaction may further enhance local vascularisation. IL2 was expressed by LTi-like 
ILC3 and NK/T cells and its receptor NFGR was expressed specifically on mLTo cells. This 
ligand-receptor interaction may facilitate LTi support for mLTo proliferation and survival in 
GALTs (Supplementary Fig. 8A). In addition, cognate receptor expression was evident 
across immune cell types that would enable their recruitment into the developing SLO 
(Supplementary Fig. 8B). For example, mLTo cells also expressed CCL2 for recruitment of 
monocytes and dendritic cells via their receptor CCR2 (Supplementary Fig. 8B).  
 
SLO developmental programmes are adapted during Crohn’s disease 
SLO development is pre-programmed and does not require antigen stimulation. In contrast, 
ectopic lymphoid structures, organised aggregates of lymphoid cells, develop in response to 
chronic inflammation 50. These ectopic structures often involve T and B cell segregation and 
increased vascularisation. Compared to SLOs, ectopic lymphoid structures are often 
transient and resolve after antigen clearance. Following on from our observations of 
lymphoid structure formation during development, we compared similarities and differences 
between normal organogenesis and ectopic lymphoid structure formation often observed in 
Crohn’s disease (CD)51.  
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We use logistic regression modeling of pediatric CD scRNAseq data 4 to calculate the mean 
prediction probability of matching fetal and pediatric CD cell types (Figure 5F). We observed 
ILC3 cells in CD that matched fetal LTi-like ILC3 with 60% probability (Figure 5F).  S4-like, 
FDCs and T reticular cells in CD matched fetal mLTo (Figure 5), the former two of which 
were expanded in four out of seven CD donors (Supplementary Fig. 8C-D). Curiously, an 
equivalent stromal population has recently been shown to be expanded in ulcerative colitis 8. 
In addition, transcriptionally similar populations are expanded in leukocyte-rich rheumatoid 
(RA) 52 and cirrhotic liver disease53 (Supplementary Fig. 8E).  
 
To determine cell types involved in CD, we calculated the enrichment score for CD-
associated GWAS gene expression for each cell type and selected top cell types (FDR 10%; 
Methods). Adult ILC3, and fetal ILCP and LTi-like ILC3 cells were among the top cell types 
enriched for expression of CD-associated genes (Figure 5G). Finally, we compared cytokine 
and chemokine expression between fetal and CD counterparts, and showed core genes 
conserved between these cells (Figure 5H). For example, ILC3 and ILCP/LTi-like ILC3 
commonly expressed CXCR4, CCL5, CCL20, while CCL4 was specific to adult ILC3. mLTo 
and CD fibroblasts showed common expression of CCL19, CCL21, CXCL12-14 and CCL2, 
while CXCL1/2/3/5/6/8 and CCL11 were specific to adult CD cells.  
 
Our identification of equivalent cell types with the same cellular networking in lymphoid 
aggregate formation in fetal and CD gut suggests a reactivation of the programs for lymphoid 
formation during disease. 
 
Discussion 
In this study, we present an integrated dataset of over 346,000 single cells of multiple 
anatomical regions of the human gut throughout development, childhood and adulthood, 
browsable online at gutcellatlas.org. We discover epithelial and neuronal lineage 
composition and developmental relationships, and reveal cell-type specific expression of 
IBD- and Hirschsprung’s disease-associated genes, respectively. We identify the three key 
cell types of mesenchymal, endothelial and innate lymphoid origins that orchestrate 
lymphoid organ formation in fetal development and show reinitiation of this cellular program 
during Crohn’s disease.  
 
In the epithelial compartment, we are able to subdivide enterocytes in unprecedented detail. 
BEST4+ enterocytes have previously been shown to function in pH sensing and transport of 
metals, ions and salts, but have been restricted to the colon 9,14,54. Here, we show their 
presence in the small and large intestines, and as early as the first trimester in the small 
intestines, supporting a consistent requirement for this population along the gut and 
throughout life. In addition, we screened for expression of the SARS-Cov2 receptor, ACE2, 
and associated protease, TMPRSS2, in the gut epithelium. We advance on previous 
observations of their expressed in epithelial cells 55 by showing their expression in 
enterocytes throughout life, including fetal development. Since amniotic fluid and placental 
tissue of an infected new mother have tested positive for SARS-Cov2 56, this could represent 
a novel route for viral transmission in utero.  
 
Continuing our analysis of the epithelial compartment, we discover that FCGR2A, a receptor 
activated by the Fc fragment of IgG upstream of PLCG2, and other downstream signaling 
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molecules are expressed by tuft cells. We suggest that this pathway could mediate direct 
immune sensing by tuft cells. This is surprising since FcG receptors have rarely been 
observed in non-haematopoietic cells 57. To our knowledge, FcgrII expression has only been 
observed in mouse intestinal epithelial cells after immunization with bacterial neurotoxin 23 
and by human nasal epithelial cells in response to bacteria-derived ligands 58. We also note 
expression of the FCGR2A by our previously described thymic mTEC(II) epithelial 
population, which expresses low levels of tuft cell transcription factor POU2F3 
(developmentcellatlas.ncl.ac.uk). FcG receptors on immune cells mediate response to local 
IgG via production of inflammatory signals. Although FCGR2A was only expressed by a 
subset of tuft cells, we expect this would similarly increase during gut inflammation when 
luminal IgG levels rise. Overall, this data suggests a novel and potentially very impactful 
immune-sensing role for intestinal tuft cells. 
 
While epithelial cells are responsible for the major absorptive and secretory functions of the 
gut, the enteric nervous system is necessary for peristalsis. Absence of the ENS is a very 
serious condition: Hirschsprung’s disease is a congenital disorder characterised by the 
absence of nerve cells.  To date, the genes associated with developmental conditions such 
as Hirschsprung’s disease have been mapped in humans using adult cells 59. We leverage 
the fetal cells of this dataset to map the expression of Hirschsprung’s disease-associated 
GWAS genes, and show expression of a set of genes including RET and EDNRB in multiple 
enteric neuronal cell types in early human gut development. We also discover for the first 
time a signaling circuitry amongst ENS and ICC and muscle cells involving Hirschsprung’s 
disease genes. These observations help explain the difficulty linking HSRC-associated 
genes with neuronal cell types in mature gut tissue.  
 
Like the ENS, the immune system of the gut is both sophisticated and essential to proper 
functioning and maintenance of this barrier tissue. Recent single-cell studies have elucidated 
the diversity and activation of immune cells in the developing human gut 60,61. Significant 
species differences exist in location and size of the SLOs 62, major hubs of immune cell 
surveillance and activation. However, our understanding of the formation of these structures 
is mostly derived from animal models. As such, using genetically perturbed mice, a three-cell 
model was proposed for SLO formation 41. Here, we identify cell types with characteristics of 
the three populations: LTi, mLTo, and eLTo (LEC) cells in the developing mucosa and mLN, 
suggesting a similar process occurs in humans. We provide detailed characterisation of 
subtypes of the LTi-like cells in both fetal and adult tissues, describing three different 
subsets of these cells. Based on previous in vitro studies, where RORC-expressing CD56+ 
CD127+ IL17A+ cells 63 and ILC3 cells 43 have been both shown to activate mesenchymal 
cells, we propose that all three of the LTi-like subsets defined in this study act in lymphoid 
tissue initiation.  
 
Previous studies point to immune cell programs that support normal development, however, 
when overactivated, can lead to inflammation in early life such as necrotising enterocolitis 
and IBD61. Here we describe SLO formation as one such program adopted in chronic 
inflammation to recruit and retain immune cells at the site of active inflammation. Using 
direct comparison of LTi subsets, mLTo and eLTo cells in development and CD, we identify 
conserved chemokine and cytokine signals between these populations, as well as point to 
CD specific signals expressed by ILC3, stromal and endothelial cells in disease.  
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Expansion of an inflammatory fibroblast population, termed Stromal 4 cells, has been 
reported in ulcerative colitis patients 8 and activated fibroblasts have been reported in adult 
and pediatric CD 4,13. Interestingly, we further observe two specialised fibroblast populations 
in pediatric CD, namely FDCs and T reticular cells. Similar cell types have been described in 
mouse lymph nodes 44, but have not been captured in the gut mucosa. Together with the 
presence of light zone and dark zone B cells in the gut (Supplementary Fig. 2B, 6F-G),  this 
suggests the presence of stromal populations involved in SLO zonation as observed in 
Peyer’s patches previously 64–67 .  
 
Direct comparison of these cells in development versus disease allowed us to separate out 
expression programs driving SLO formation in development or disease. We show that mLTo-
like fibroblasts in CD have unique expression of cytokines and chemokines (e.g CXCL2-8) 
associated with increased recruitment of monocytes and neutrophils to the site of 
inflammation that may be driving ectopic lymphoid formation. In fetal LTi-like cells, we 
observed expression of IL2 and IL17A. These inflammatory cytokines may also contribute to 
controlled inflammatory reaction in the developing fetus, aiding establishment of organised 
lymphoid tissues prior to birth 68. While others have proposed that small numbers of LTi-like 
NK cells are present in post-natal tonsils 63, we do not observe ILCPs or LTi-like NK/T cells 
in the pediatric or adult gut. Rather, we show transcriptional similarities between ILC3 and 
fetal LTi-like ILC3 cells. It is possible that ILC3 in CD may act as an initiator cell to activate 
the mesenchymal cells and recruit other lymphocytes to the site of inflammation.  
 
Overall, our detailed cell annotation of the human intestine across time and space can be 
mined for cell-type expression of genes associated to any number of intestinal tract 
diseases. For instance, our identification of cellular programs of prenatal SLO development 
reactivated during ectopic lymphoid tissue in CD may represent a target for controlling 
inflammation during this disease, and could also be extended to other inflammatory diseases 
characterised by ectopic lymphoid structure formation  69. Finally, this work opens avenues 
for using principles of prenatal development and differentiation trajectories outlined here for 
stromal, epithelial, ENS and immune compartments, to engineer human cells  and guide cell 
maturation in vitro, for the purposes of basic research or even screening, and ultimately as 
therapeutics for regenerative medicine.   
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Figure 1: Intestinal cellular census throughout life 
A) Schematic of tissue sampling of healthy human gut. Number of individual donors 
sampled are shown in parentheses. B) UMAP visualisation of cellular landscape of 
the human intestinal tract coloured by cellular lineage. C) Relative proportions of cell 
lineage as in B per anatomical tissue.  D) Proportions of BEST4+ enterocytes among 
all epithelial cells per tissue region and developmental stage. E) Expression of 
BEST4 (antibody: HPA058564) and CSTE (antibody: CAB032687) in gut histological 
sections from Human Protein Atlas (proteinatlas.org). F) Dotplot with relative 
expression of small and large common and small intestine specific BEST4+ 
enterocyte marker genes.  
 
Figure 2: Identification of FCGR2A signalling in tuft cell and its contribution to IBD  
A) UMAP visualisation of fetal (left) and postnatal (pediatric and adult; right) epithelial 
cells coloured by cell type. Key cell types discussed within text are circled with a 
dashed line. B) Relative proportions of subtypes within total epithelial cell faction 
separated by donor age (row). Units of age is years unless specified as weeks. C) 
Dot plot of expression of TMPRSS2 and ACE2 by epithelial cell types in the fetal 
intestine. Here and in later figures, color represents maximum-normalized mean 
expression of marker genes in each cell group, and size indicates the proportion of 
cells expressing marker genes. D) Heatmap displaying the expression of Crohn’s 
disease and ulcerative colitis genes from GWAS by pediatric and adult gut epithelial 
cells. Only differentially expressed genes between epithelial cells types and with a 
mean expression of 0.5 normalised counts are included. Scale bar has an upper limit 
of 1.5 normalised mean expression. E) Dotplot of expression of key molecules 
involved in PLCB2 and PLCG2 upstream activation and downstream signalling in tuft 
cells and pooled absorptive (TA and enterocytes) and secretory (paneth, goblet and 
enteroendocrine (EECs)) epithelial cells in the dataset. F) Percent expression of FCү 
receptor by SiglecF+EpCAM+ and SiglecF-EpCAM+ cells in wild type mice 
determined by flow cytometry (n=4). P values were calculated using 2-way ANOVA 
with Sidak multiple comparisons. ****<0.0001. G) Summary schematic of signalling 
pathways of tuft cells shown in E.  
 
Figure 3: Hirschsprung’s disease risk gene expression in developing human enteric 
nervous system 
A) UMAP projection of fetal enteric neural crest cell progenitors and their progeny 
coloured by cell cycle score. B) UMAP projection as in A) colored by the glial (left) or 
neuronal (right) score. Scores were calculated using glial (SOX10, MPZ, S100B, 
ERBB3, PLP1, GAS7, COL18A1, EDNRB) and neuronal (ELAVL3, ELAVL4, 
TUBB2B, PHOX2B, RET, CHRNA3) genes. C) UMAP projection as in A) colored by 
cell type. The overlaid arrows show scVelo derived differentiation trajectory. Selected 
marker genes are listed for each population. Multiplex smFISH visualisation of D) 
myelin Schwann-like cells (scale bars: 100 μm main panel, 30 μm zoom panels), E) 
three neuronal subtypes described in the fetal 15PCW ileum (scale bars main and 
zoom panels 100 μm). Arrows highlight three subsets of ELAVL4+ cells expressing 
either SCGN (greeen), GRP (red) or BCN2 (yellow) genes. F) Dotplot with key 
Hirschsprung’s disease-associated ligand-receptor genes in the whole fetal dataset. 
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TF= transcription factor, Prog = progenitor. G) Summary schematic of signalling 
involved in Hirschsprung’s disease as in F.   
 
Figure 4: Lymphoid tissue inducer cells in gut-associated lymphoid tissues  
A) UMAP visualization of T and innate-like cells in fetal, pediatric and adult samples. 
Dotted line denotes lymphoid tissue inducer (LTi)-like cell types. B) Bar graph 
showing the relative proportion (%) of cell types among total T and innate-like 
lymphocyte population as in A across developmental timepoints. C) Relative 
expression of key defining and novel marker genes expressed in lymphoid tissue 
inducer cell types as compared to NK cells. D) Schematic of three LTi-like 
populations and their features described in this study. E) Multiplex smFISH staining 
of CXCL13 (green), RORC (yellow) and CXCR5 (red) in fetal ileum tissue at 15 
PCW. The boxed area is shown at higher magnification below. Arrows highlight 
CXCR5+RORC+ co-expressing cells. Scale bar main panel=100 μm, zoom panel=50 
μm. 
 
Figure 5: Lymphoid tissue organogenesis programs adopted in Crohn’s disease  
A) UMAP projection of fetal, pediatric and adult stromal cells colored by cell type. Zoom 
in panel shows mLTo cells, S4-like, follicular dendritic (FDC), and T reticular cells. B) 
Bar plot showing number of mesenchymal lymphoid tissue organiser cells (mLTo) 
captured in the dataset and colored by gut region. C) Feature plot with cells co-
expressing CXCL13, CCL19, and CCL21. D) Heatmap showing scaled expression of 
selected genes involved in lymphoid tissue organisation in model organisms.  E) H&E 
staining of cross-section of fetal colon (15 PCW). Magnified panels show developing 
vessels. F) Heatmap showing mean probability of cell types matching between fetal 
and Crohn’s disease stromal cell populations. G) Top cell types across fetal, 
pediatric, and adult data enriched in genes associated with Crohn’s disease (FDR 
10%). H) Heatmap with expression of cytokines and chemokines in cells involved in 
tertiary lymphoid organ development of fetal (black) and functionally related cell types 
in pediatric Crohn’s disease (red).  
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Supplementary Figures:  
Supplementary Fig. 1: Data quality control. A) Schematic with tissue processing strategy 
for second trimester fetal and adult samples. After enzymatic dissociation, either total 
fraction was loaded onto 10X chip or CD45+/- cell factions were separated using magnetic 
cell sorting (MACS) and both fractions were loaded on the 10X chip separately. Lymph 
nodes were processed without enrichment. Second trimester fetal and adult cell samples 
were processed using 5’ v2 10X kits (Methods). B) Pre-processing and quality control of 
single-cell RNA-seq data generated in this study and described previously4. In short, four 
datasets, namely first trimester fetal, second trimester fetal, pediatric and adult, were pre-
processed separately (including quality control and scrublet doublet removal). Firstly, 
dimension reduction, clustering and annotation by cell lineage was performed on each 
dataset separately. Each cell lineage was sub-clustered and fine-grained cell type and state 
annotation was performed based on marker gene expression. The four datasets were then 
merged together and each lineage was sub-clustered to unify cell type labels where 
appropriate. UMAP visualisations show combined dataset colored by sample age, 
enrichment fraction and donor name.  
 
Supplementary Fig. 2: Cell types defined in the study and intestinal region variability 
in BEST4+ enterocytes. A) Bar plots with relative proportion (%) of cell lineages in each 
sample grouped by anatomical region within the scRNAseq dataset as in Figure 1B. B) Dot 
plot for expression of marker genes of cell types and states in each cell lineage in scRNAseq 
dataset. C) UMAP visualisation of BEST4+ enterocytes colored by key marker 
BEST4/OTOP2 expression and region group (fetal and pediatric/adult). D) Volcano plot for 
differential abundance (DA) between cells from small intestine and large intestine. Each 
point represents a neighbourhood of BEST4+ enterocytes (FDR: False Discovery Rate, 
logFC: log-Fold Change). The results for the DA test in adult samples (red) and fetal 
samples (blue) are shown. The dotted line indicates the significance threshold of 10% FDR. 
E) Heatmap showing average neighbourhood expression of genes differentially expressed 
between DA neighbourhoods in Adult BEST4+ enterocytes (1502 genes). Expression values 
for each gene are scaled between 0 and 1. Neighbourhoods are ranked by log-fold change 
in abundance between conditions. Genes highlighted in red are specific to small intestinal 
BEST4+ enterocytes F) Expression of CFTR (antibody: CAB001951) in small intestinal (top) 
and colonic (bottom) histological sections from Human Protein Atlas (proteinatlas.org). 
 
Supplementary Fig. 3: Epithelial cell types throughout intestinal life. A) UMAP 
projection of detail (left) and pooled pediatric and adult (right) epithelial cells coloured by gut 
region. B) Bar plots with number of epithelial cells subtypes separated by donor age (row). 
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Units of age is years unless specified as weeks. C) Violin plot with MHCII score in M cells. 
D) Dot plot of expression of TMPRSS2 and ACE2 by epithelial cell types in pediatric (top) 
and adult (bottom) intestine. E) Bar plot showing mean expression of PLCG2 in all epithelial 
cells grouped by developmental/disease phenotype, where each dot is a donor and 
confidence interval is standard deviation. F) Representative brightfield images of pediatric 
intestinal organoid line (derived from healthy donors) without (NT) or with stimulation with 
inflammatory recombinant human proteins IFN-gamma or TNF-alpha. Scale bar = 400 μm. 
G) Bar plot showing mean expression of PLCG2 in all intestinal organoid cells grouped by 
stimulation condition, where each dot is corganoid line (n=3) and confidence interval is 
standard deviation. H) Heatmap with top differentially expressed genes in tuft cells. The 
legend indicates whether the gene has known association with tuft cells (purple) or are novel 
(orange). I) Immunohistochemical staining of HPGDS (antibody: HPA024035), PSTPIP2 
(antibody: HPA040944), BMX (antibody: CAB032495), MYO1B (antibody: HPA060144), 
FYB1 (antibody: CAB025336), SH2D7 (antibody: HPA076728), PLCG2 (antibody: 
HPA020099) in small intestine from Human Protein Atlas (proteinatlas.org). J) Heatmap of 
expression of IgG receptors (green) and chemosensing (yellow) and downstream signalling 
molecules as in Figure 2E for epithelial cells with B and myeloid cells for reference. K) 
Dotplot showing expression of ITAM- and ITIM-linked receptors and receptor tyrosine 
kinases across tuft cells and pooled absorptive (TA and enterocytes) and secretory (paneth, 
goblet and EECs) epithelial cells. L) Representative flow cytometry plots of FcүRII/III staining 
on EpCAM+SiglecF- (non-tuft epithelial cells) and EpCAM+SiglecF+ (tuft cells) cells and 
Isotype staining of EpCAM+SiglecF+ cells. Numbers show the percentage of cells within the 
gate out of the total population. 
 
Supplementary Fig. 4: Cell types in the developing enteric nervous system. A) Feature 
plots with overlaid expression of key genes (RET, EDNRB, SOX10) that define enteric 
neural crest cells (ENCCs). B) Area plot with relative abundance (percentage %) of cell 
types amongst ENCC-lineage populations as described in Figure 3C across developmental 
timepoints. C) Dotplot with differentially expressed genes in ENCC-lineage subsets as 
described in Figure 3C. Genes in red are discussed in text. D) PAGA visualisation of ENCC-
lineage cells. Red arrows show ENCC division to committed progenitors. E) UMAP 
visualisation of ENCC-lineage cells colored by monocle 3 pseudotime. Arrows show 
differentiation to neuronal branches. F) Heatmap showing genes that change across 
pseudotime in three neuronal branches shown with arrows in E. G) Multiplex smFISH 
staining of non-myelin Schwann cells using probes for BMP8B (green), MPZ (yellow) and 
SOX10 (red) in fetal ileum tissue at 15 PCW. The boxed area is shown at higher 
magnification below. Scale bar main panel=100 μm, zoom panel=30 μm. H) UMAP 
visualisation of ENCC-lineage cells colored by intestinal anatomical region. I)  Heatmap with 
relative mean expression of genes associated Hirschprung’s disease in humans and ENS 
defects in mice (not determined). Mean expression was calculated and visualised for small 
and large intestinal regions separately. J) Dotplot with mature neuron gene expression in 
developing neuronal branches. PEMN- putative excitatory motor neurons; PIMN- putative 
inhibitory motor neurons; PSVN- putative secretomotor/vasodilator neurons; PIN- putative 
interneurons; PSN-putative sensory neuron 
 
Supplementary Fig. 5: Identification of LTi cell-like subsets. A) Photo images of human 
intestinal gut and developing lymph nodes (arrows) in 8-17 PCW samples. Scale bar = 1cm. 
B) Bar plot with productive TCRαβ chain in fetal T and innate lymphoid cell types. C) 
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Heatmap with scaled expression of selected differentially expressed genes in fetal LTi-like 
subsets, NK cells and adult ILC3 cells. D) UMAP visualisation and feature plots of Smart-
seq2 processed flow cytometry-sorted CD45+ cells from second-trimester fetal tissue. 
UMAP visualisations are colored by intestinal region or leiden clustering. Feature plots show 
key gene expression described using 10X data. E) Bar graph showing the relative proportion 
(%) of cell types among total T and innate lymphocyte population across developmental and 
adult gut regions (FPIL- fetal proximal ileum, FMIL- fetal middle ileum, FTIL- fetal terminal 
ileum, FLI- fetal large intestine, FMLN- fetal mesenteric lymph node, DUO- duodenum, JEJ-
jejunum, ILE-ileum, APD-appendix, CAE-caecum, ACL-ascending colon, TCL-transverse 
colon, DCL-descending colon, SCL-sigmoid colon, REC-rectum, MLN- mesenteric lymph 
node). F)  UMAP visualisation with overlaid RNA velocity arrows of lymphocytes from fetal 
tissues colored by cell type. Zoom in panel shows ILCP and LTi-like ILC3 cells.  
 
Supplementary Fig. 6: Intestinal B cells and BCR analysis. UMAP visualizations of B 
cells from fetal samples. CLP- common lymphoid progenitor B) Heatmap with mean 
expression of differentially expressed gene in fetal B cell populations as in A). C) Violin plot 
with MHCII score of fetal B cell subsets. UMAP visualisation colored by D) BCR isotype 
retrieved from 10X VDJ sequencing and E) 10x Genomics technology. BCR sequencing is 
available only for cells processed using 5’ 10x Genomics scRNA-seq technology. F) UMAP 
visualizations of B cells from pediatric and adult samples. LZ - light zone, DZ- dark zone, GC 
- germinal centre. G) Relative proportions (left) and count (right) of subtypes within total B 
cell factions in the small (above) and large (below) intestine separated by donor age (row). 
Units of age is years unless specified as weeks. H) Estimated clonal abundances per donor 
for members of expanded B cell clones in fetal and adult datasets. I) Quantitation of somatic 
hypermutation frequencies of IgH sequences from B cells in fetal and adult datasets. J) 
Quantitation of somatic hypermutation frequencies of IgH sequences (J) and Estimated 
clonal abundances per donor for members of expanded B cell clones (K)  in gut regions 
(FPIL- fetal proximal ileum, FMIL- fetal middle ileum, FTIL- fetal terminal ileum, FLI- fetal 
large intestine, FMLN- fetal mesenteric lymph node, DUO- duodenum, JEJ-jejunum, ILE-
ileum, APD-appendix, CAE-caecum, ACL-ascending colon, TCL-transverse colon, DCL-
descending colon, SCL-sigmoid colon, REC-rectum, MLN- mesenteric lymph node). L) 
Binary count of co-occurrence of expanded B cell clones identified by single-cell VDJ 
analysis shared across gut regions and donors.  
 
Supplementary Fig. 7: Stromal and endothelial populations in the intestinal tract. A) 
Heatmap with top differentially expressed genes between follicular dendritic cells (FDCs) 
and T reticular cells. B) Bar graph showing the relative proportion (%) of cell types among 
total stromal population across developmental and adult gut regions (FPIL- fetal proximal 
ileum, FMIL- fetal middle ileum, FTIL- fetal terminal ileum, FLI- fetal large intestine, FMLN- 
fetal mesenteric lymph node, DUO- duodenum, JEJ-jejunum, ILE-ileum, APD-appendix, 
CAE-caecum, ACL-ascending colon, TCL-transverse colon, DCL-descending colon, SCL-
sigmoid colon, REC-rectum, MLN- mesenteric lymph node). C) Dendrogram plot of 
mesenchymal cells. D) Dotplot comparing key defining genes expressed across mLTo, FDC 
and T reticular cells. E) Heatmap of top differentially expressed genes between mLTo cells 
of different intestinal regions (FSI - fetal small intestine, FLI- fetal large intestine, FMLN- fetal 
mesenteric lymph nodes). UMAP projection of endothelial cell populations in fetal, pediatric 
and adult colored by annotation F) or cell cycle score G). Dashed line outlines lymphatic 
endothelial cell subsets (LEC). H) UMAP visualisation of subclustered LECs colored by cell 
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cycle, subpopulation and sample age. I) Heatmap with top differentially expressed genes in 
the LEC subsets. J) Relative proportions (left) and count (right) of subtypes within total LEC 
factions separated by age (above) and intestinal region (below). Units of age is years unless 
specified as weeks. Region names are as in B). K) Feature plots with expression of 
lymphatic cells genes and key genes for lymphocyte adhesion. L) Violin plot of NFkB 
signalling activation score across LEC subpopulations.  
 
Supplementary Fig. 8: Ectopic lymphoid tissue formation in pediatric Crohn’s disease. 
A) Heatmap with mean expression of ligand-receptor pairs in mLTo, LTi-like and LEC 
subsets as identified using CellphoneDB. B) Heatmaps with mean expression of curated 
immune recruitment signal genes in selected fetal stromal, epithelial and endothelial 
populations (top) and their receptor expression in the immune populations found in the fetal 
gut and mesenteric lymph nodes. C) UMAP visualisation of mesenchymal, smooth muscle 
and pericyte cell subsets in pediatric healthy and Crohn’s disease intestine colored by 
disease phenotype (left) and cell type annotation (right). mLTo-like cells are outlined using a 
dashed line. UMAP visualisation with overlaid RNA splicing and colored by pseudotime. D) 
Bar plots with number of cells in each donor grouped as control and Crohn’s disease (CD). 
E) Heatmap of genes reported in expanded mesenchymal cells in Rheumatoid arthritis (RA) 
or liver cirrhosis expressed by mLTo and mLTo-like cells in CD with enterocytes shown for 
reference.  
 
Supplementary Table1: Sample metadata  
Supplementary Note Section 1: Related to the cell type enrichment for IBD-GWAS genes 
analysis 
 
Materials and Methods  
Patient samples 
Human fetal gut samples were obtained from the Human Developmental Biology Resource 
(HDBR, www.hdbr.org). The maternal consent was obtained through Newcastle hospital (the 
consent REC reference 18/NE/0290- IRAS project ID: 250012). Pediatric patient material 
used in intestinal organoid culture was obtained with informed consent as part of the 
ethically approved research study (REC-96/085). 
 
Human adult tissue was obtained by the Cambridge Biorepository of Translational Medicine 
from deceased transplant organ donors after ethical approval (reference 15/EE/0152, East of 
England—Cambridge South Research Ethics Committee) and informed consent from the 
donor families. Fresh mucosal intestinal tissue and lymph nodes from the intestinal 
mesentery were excised within 1 hour of circulatory arrest; intestinal tissue was preserved in 
University of Wisconsin organ-preservation solution (Belzer UW Cold Storage Solution; 
Bridge to Life) and mLN were stored in saline at 4°C until processing. Tissue dissociation 
was conducted within 2hours of tissue retrieval. 
 
Mouse samples 
C57BL/6 mice were obtained from Jackson Laboratories (Margate, UK) and maintained in 
specific pathogen-free conditions at a Home Office-approved facility at the University of 
Cambridge. Female mice ages 10 to 14 weeks were used. Mice were housed in accordance 
with the United Kingdom Animals (Scientific Procedures) Act of 1986. 
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Isolation of intestinal cells from fetal tissue 
The fetal gut mesentery was cut to lengthen out the tissue and dissected into proximal ileum 
(PI), middle Ileum (PI), terminal Ileum (TI), colon and appendix. Samples were washed twice 
with Hanks Buffered Saline Solution (HBSS; Sigma-Aldrich; cat: 55021C) and minced into 
pieces using a scalpel. The samples were incubated in 2 ml HBSS solution containing 0.21 
mg/ml Liberase TL (Roche; cat: 5401020001) or DH (Roche; cat: 5401089001) and 70 U/ml 
hyaluronidase (Merck; cat: 385931-25KU) for 50 minutes at 37°C shaking every 5 minutes 
and homogenised every 15 minutes using a pipette. The single cells were passed through a 
40-100 μm sieve and spun down at 400 g at 4°C for 10 minutes. Red cell lysis solution 
(eBioscience™ 10X RBC Lysis Buffer (Multi-species) was used according to manufacturer’s 
guidelines to remove red blood cells, and the remaining cells were collected in FACS buffer 
(1% (v/v) FBS in PBS) by centrifugation at 400 g at 4°C for 5 minutes. All gut region samples 
(except mLN) proceed to MACS enrichment.  
 
Isolation of intestinal cells from adult tissue 
Adult tissue sections were weighed before being washed in cold D-PBS (Gibco; cat: 
14190094) and diced with a scalpel. Samples were dissociated in 1-2 ml of digestion mix (D-
PBS, 250ug/ml Liberase TL (Roche; cat: 5401020001), 0.1 mg/ml DNaseI (Sigma; cat: 
11284932001)) for 30 minutes at 37°C. Digested lysates were then passed through a 70 μm 
cell strainer, followed by 10 ml of neutralisation media (RPMI 1640 Medium with HEPES 
(Gibco; cat: 42401042), 20% (v/v) FBS (Sigma; cat: 25200-056)). The samples were then 
centrifuged at 700 g for 5 minutes at 4°C. Cells were resuspended in 1 ml 0.04% (w/v) BSA 
in D-PBS and counted using a NucleoCounter NC-200 and Via1-Cassette (ChemoMetec).  
 
MACS enrichment 
Samples with greater than 500,000 cell yield were enriched by magnetic-activated cell 
sorting (MACS). Dissociated cells were centrifuged for 5 minutes at 300 g at 4°C and 
resuspended in 80 μl chilled MACS buffer (D-PBS, 0.5% (w/v) BSA (Sigma-Aldrich; cat: 
A7906-10G), 2 mM EDTA (ThermoFisher; cat: 15575020)) with 20 μl CD45 MicroBeads 
(Miltenyi Biotech; cat: 130-045-801) and incubated for 15 minutes at 4°C. Cells were washed 
with 2 ml MACS buffer and centrifuged as above and resuspended in 500 μl MACS buffer. 
Cells were passed through a pre-wetted MS column (Miltenyi Biotech; cat: 130-042-201) on 
a QuadroMACS Magnetic Cell Separator (Miltenyi Biotech) followed by four rounds of 500 μl 
of MACS buffer. Flowthrough was collected as the CD45- fraction. The column was removed 
from the magnet and the CD45+ fraction was eluted with 1 ml of MACS buffer. CD45- and 
CD45+ fractions were centrifuged as above and resuspended in 0.5-1 ml of 0.04% (w/v) 
BSA in D-PBS. Cell count and viability was determined using NucleoCounter NC-200 and 
Via1-Cassette (ChemoMetec) or hemocytometer and resuspended in 0.04% (w/v) BSA in D-
PBS. Fetal CD45+ and CD45- fractions were combined at a 1:1 ratio. 
 
Organoid culture  
Intestinal organoids from pediatric patients were cultured in Matrigel® (Corning) using media 
described before. During organoid culture, the media was replaced every 48-72 hours. 
Organoids were passaged using mechanical disruption with a P1000 pipette and re-seeded 
in fresh growth-factor reduced Matrigel® (Corning). When comparing culture media, multiple 
wells were seeded from a single dissociated sample. The organoids were then allowed to 
grow for 5 days followed by 24 hour treatment with recombinant human protein TNF-α 
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(H8916, Sigma Aldrich) at 40ng/ml or IFN-gamma (PHC4031, Life Technologies Ltd) at 
20ng/ml. 
Processing for single-cell sequencing analysis was performed by removing the organoids 
from matrigel at passage 3-4 using incubation with Cell Recovery Solution at 4oC for 20 
minutes, pelleting the cells, and re-suspending in TrypLE enzyme solution (Thermo Fisher) 
for incubation at 37oC for 10 mins. Cells were pelleted again and re-suspended in 
DMEM/F12. 
 
10x Genomics Chromium GEX library preparation and sequencing 
MACS enriched and total cell factions were loaded for droplet-based scRNA-seq according 
to the manufacturer’s protocol for the Chromium Single Cell 5′ gene expression v.2 (10x 
Genomics) to obtain 8,000-10,000 cells per reaction. Library preparation was carried out 
according to the manufacturer’s protocol. Pools of 16 libraries were  sequenced across both 
lanes of an Illumina NovaSeq 6000 S2 flow cell with 50bp paired-end reads.  
Intestinal organoids were prepared Chromium Single Cell 3′ gene expression v.2 (10x 
Genomics) to obtain 8,000 cells per reaction. Intestinal organoid cDNA libraries were 
sequenced on a single lane of an Illumina HiSeq 4000 with 50 bp paired-end reads.  
 
VDJ sample preparation 
10x Genomics VDJ libraries were generated from the 5′ 10x Genomics Chromium 
complementary DNA (cDNA) libraries as detailed in the manufacturer’s protocol. BCR and 
TCR libraries for relevant samples were pooled and sequenced on a single lane of an 
Illumina HiSeq 4000 with 150bp paired-end reads.  
 
Plate-based Smart-seq2  
Plate-based scRNA-seq was performed with the NEBNext Single Cell/Low Input RNA 
Library Prep Kit for Illumina (catalog no. E6420L; New England Biolabs). Total cell fractions 
from dissociated gut sections of donors BRC2033-2034, F67, F72, F78 were snap-frozen in 
10% (v/v) DMSO in 90% (v/v) BSA. Cells were thawed rapidly in a 37°C water bath and 
diluted slowly with a pre-warmed FACS buffer (2% (v/v) FBS in D-PBS). Cells were pelleted 
by centrifugation for 5min at 300 g, washed with 300µl of D-PBS and pelleted as before. 
Cells were resuspended in 100 μl of Zombie Aqua Fixable Viability Kit (1:200 dilution; 
catalog no. 423101) and incubated at room temperature for 15 minutes. Cells were washed 
with 2 ml of FACS buffer followed by 300 μl of FACS buffer and resuspended in a total of 
100 μl of Brilliant Violet 650 mouse anti-human CD45 (Biolegend catalog no. 304043), Alexa 
Fluor 700 mouse anti-human CD4 (Biolegend, catalog no. 300526), and APC-H7 mouse 
anti-human CD19 (BD biosciences, catalog no. 560727) and incubated for 20minutes in 
the dark at room temperature. Cells were washed twice with 300µl of FACS buffer. Single, 
live, CD45+ cells were FACS sorted into wells of a 384-well plate (catalog no. 0030128508; 
Eppendorf) containing 2µl of 1× NEB Next Cell Lysis Buffer (New England Biolabs). FACS 
sorting was performed with a BD Influx sorter (BD Biosciences) with the indexing setting 
enabled. Plates were sealed and spun at 100 g for 1 min then immediately frozen on dry ice 
and stored at −80°C. cDNA and sequencing library generation was performed in an 
automated manner on the Bravo NGS Workstation (Agilent Technologies) as previously 
described 
6. The purified pool was quantified on an Agilent Bioanalyzer (Agilent 
Technologies) and sequenced on one lane of an Illumina HiSeq 4000. 
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Pre-processing of Smart-seq2 sequencing data 
Cells with greater than 6000 genes and more than 25% mitochondrial reads were excluded, 
before regression of 'n_counts', 'percent_mito' and "G2M_score". Cells positive for PTPRC 
expression (logTPM+1 >=0.2) were taken forward for downstream analysis. 
 
Pre-processing of 10x sequencing data  
10x Genomics gene expression raw sequencing data were processed using the CellRanger 
software v3.0.0-v3.0.2 and the 10X human transcriptome GRCh38-3.0.0 as the reference. 
The 10x Genomics VDJ Ig heavy and light chains were processed using cellranger vdj 
v.3.1.0 and the reference cellranger-vdj-GRCh38-alts-ensembl-3.1.0 with default settings.  
 
scRNA-seq quality control and processing of 10x sequencing data  
Pandas (version 0.24.2), NumPy (version 0.25.2), Anndata (version 0.6.19) and ScanPy 
(version 1.4) python packages were used to pool single-cell counts and for downstream 
analyses. Single-cell transcript counts for fetal and adult samples were handled separately to 
control for anticipated differences in cell expression and sample quality. Cells for each 
dataset were filtered for greater than 500 genes and less than 50% mitochondrial reads, and 
genes were filtered for expression in greater than 3 cells.  Scrublet (version 0.2.1) score cutt-
off of 0.25 was applied to assist in doublet exclusion. Additional doublet exclusion was 
performed throughout downstream processing based on unexpected co-expression of 
canonical markers such as CD3D (component of the TCR) and EPCAM. Gene expression 
for each cell was normalised and log transformed. Cell cycle score was calculated using 
expression of 97 cell cycle genes listed in Tirosh et al. 2015 70. Cell cycle genes were then 
removed for initial clustering. Cell cycle score, mitochondrial reads percentage and unique 
molecular identifiers (UMIs) were regressed prior to scaling the data.  
 
Cell type annotation and scoring 
Batch correction of fetal and adult datasets were performed with bbknn (version 1.3.9, 
neighbours=2-3, metric='euclidean', n_pcs=30-50, batch_key = “fetal_id” or “batch”), and 
dimensionality reduction and leiden clustering (resolution 0.3-1.5) was carried out and cell 
lineages were annotated based on marker gene expression for each cluster. Cell lineages 
were then subclustered and cell cycle genes reintroduced for batch correction and leiden 
clustering for annotation of cell types and states again based on marker gene expression. 
Annotated fetal and adult datasets were then merged and annotations adjusted for 
concordance.  
For MHCII scoring of M cells and B cells we use the following genes: SECTM1, CD320, 
CD3EAP, CD177, CD74, CIITA, RELB, TAP2, HLA-DRA, HLA-DRB5, HLA-DRB1, HLA-
DQA1, HLA-DQB1, HLA-DQB1-AS1, HLA-DQA2, HLA-DQB2, HLA-DOB, HLA-DMB, HLA-
DMA, HLA-DOA, HLA-DPA1, HLA-DPB1. Glial or neuronal cell signature score was 
calculated using the curated gene sets (glial: SOX10, MPZ, S100B, ERBB3, PLP1, GAS7, 
COL18A1, EDNRB; neuronal: ELAVL3, ELAVL4, TUBB2B, PHOX2B, RET, CHRNA3). 
The scoring was done using sc.tl.score_genes() function with default parameters to calculate 
the average expression of selected genes substrated with the average expression of 
reference genes. 
 
Intestinal organoid analysis 
Single-cell count matrices from three organoid growth conditions were combined together 
using Pandas (version 0.24.2) and NumPy (version 0.25.2) packages. Cells with fewer than 
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8000 genes and with less than 20% mitochondrial reads were included in the analysis. 
Genes with expression in fewer than 3 cells were also excluded. For PLCG2 expression 
comparison we use normalised (sc.pp.normalize_per_cell) and log transformed (sc.pp.log1p) 
counts. The data was plotted using Seaborn package barplot and swarmplot functions  
(version 0.11.0).  
 
Differential cell-state abundance analysis for BEST4+ cells 
To identify region-specific subpopulations, we performed compositional analysis between 
BEST4+ enterocytes from small and large intestine tissue, using an unpublished tool for 
differential abundance testing on KNN graph neighbourhoods (implemented in the R 
package miloR  https://github.com/MarioniLab/miloR). 
Briefly, we performed PCA dimensionality reduction and KNN graph embedding on the 
BEST4+ enterocytes. We define a neighbourhood as the group of cells connected to a 
sampled cell by an edge in the KNN graph. Cells are sampled for neighbourhood 
construction using the algorithm proposed previously 71. For each neighbourhood we then 
perform hypothesis testing between conditions to identify differentially abundant cell states 
whilst controlling the FDR across the graph neighbourhoods. 
We test for differences in abundance between the cells from small and large intestine tissue 
in adult samples and fetal samples. To identify markers of SI-specific and LI-specific 
subpopulations, we performed differential gene expression analysis using a linear model 
implemented in the package limma 72, using 1% FDR (implemented in the function 
findNhoodMarkers of the miloR package). 
 
RNA velocity, monocle 3 and diffusion map pseudotime analyses 
For neuronal cell trajectory analysis we use scVelo 0.21 package implementation in Scanpy 
1.5.1 73. The data was sub-clustered on fetal neuronal cells and pre-processed using 
functions for detection of minimum number of counts, filtering and normalisation using 
scv.pp.filter_and_normalise and followed by scv.pp.moments function. The gene-specific 
velocities were obtained using scv.tl.velocity(mode='stochastic') and scv.tl.velocity_graph() 
by fitting a ratio between unspliced and spliced mRNA abundances. The gene specific 
velocities were visualised using scv.pl.velocity_graph() or scv.pl.velocity_embedding_grid() 
functions.  
In addition, we calculate pseudotime using Monocle 3 0.2.1 (R version 3.6.3) 74–77In short, we 
use preprocess_cds(num_dim=100) to normalise and pre-process raw counts, and reduce 
dimension and cluster cells using functions  reduce_dimension(reduction_method = 'UMAP') and 
cluster_cells(). We then use functions learn_graph() and order_cells( root cell = 
“GTATTCTGTCATGCCG-1-4918STDY7426908” ) to order cells along the pseudotime. We then 
overlay the pseudotime onto the UMAP with velocyto arrows using 
scv.pl.velocity_embedding_grid() with clusters set to monocle3 inferred “pseudotime”. To 
visualise genes that change along the pseudotime we use sc.pl.paga_path() function with 
pseudotime set to monocle3 pseudotime. This function required calculation of PAGA parameters 
and dpt_pseudotime with functions as follows: sc.tl.paga(), sc.pl.paga(), sc.tl.draw_graph( 
init_pos='paga'), sc.tl.dpt() 78.  
 
BCR analysis 
Single-cell BCR analyses were performed as described previously 79. Briefly, poor quality or 
incomplete VDJ contig sequences were discarded and all IgH sequences for each donor 
were combined together. IgH sequences were annotated with IgBLAST 80 before isotype 
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reassignment using  AssignGenes.py (pRESTO; 81). Ambiguous V gene calls were corrected 
using TIgGER v.03.1 82 before identifying clonally-related sequences with DefineClones.py 
(ChangeO v.0.4.5; 82) using a threshold of 0.2 for nearest neighbour distances. The germline 
IgH sequence for each clonal family was determined using CreateGermlines.py (ChangeO 
v.0.4.5) followed by using observedMutations (Shazam v.0.1.11; 82) to calculate somatic 
hypermutation frequencies for individual sequences. Finally, for integration with the single-
cell gene expression object, the number of high quality and annotated contigs per Ig chain 
(IgH, IgK, IgL) was determined for each cell barcode. If multiple unique sequences for a 
given chain were detected, that cell was annotated as “Multi” and not considered in further 
analysis. BCR metadata was combined with the scRNA object for downstream analysis and 
comparison of different B cell populations. 
 
Cell-cell communication analysis 
To infer cell-cell communication and screen for ligand-receptors involved we applied 
CellPhoneDB v2.0 python package 83,84 on the normalised raw counts and fine cell type 
annotations from the second trimester intestinal samples (12-17 PCW). We use default 
parameters and set subsetting to 5000 cells. To identify most relevant interactions, we 
subset specific interactions based on the ligand/receptor expression in more than 10% of 
cells within a cluster and where the log2 mean expression of the pair is greater than 0.  
 
Enteric nervous system disease-linked gene expression  
Hirschsprung’s disease genes were curated from 35–37 and The Human Phenotype Ontology 
website (see URL: https://hpo.jax.org/app/, Aganglionic megacolon HP:0002251) and we 
selected genes with higher than or equal to 0.3 expression in neuronal lineage single cells. 
We calculated mean expression per cluster and organ and visualised the normalised mean 
expression (standard_scale=”var”) using seaborn.clustermap() function (version 0.11.0).  
 
IBD-GWAS gene expression analysis in epithelial cells in Figure 2D 
Crohn’s disease (EFO_0000384) and ulcerative colitis (EFO_0000729) gene names were 
retrieved from GWAS Catalog of EMBL-EBI (https://www.ebi.ac.uk/gwas/). The list was 
downloaded on 27 May 2020. We took the intersecting genes from pooled GWAS genes (P 
value < 1.00E-6) and the top 100 positive and 100 negative differentially expressed marker 
genes for each epithelial cell type versus all other epithelial cell types. Expression colour 
scale has a maximum cut off of 1.5 mean normalised counts to increase resolution at lower 
expression levels. Only cell types present are shown in each respective gut region heatmap.  
 
Cell type enrichment for IBD-GWAS genes 
IBD GWAS summary statistics of Crohn’s disease (CD) and ulcerative colitis (UC) were 
obtained from the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC) 
(see URL: https://www.ibdgenetics.org/). The GWAS enrichment analysis of 103 annotated 
gut cell types for CD and UC was performed using a fGWAS approach 85,86, often used for 
fine-mapping and enrichment analysis of various functional annotations for molecular 
quantitative trait and GWAS loci. The association statistics (log odds ratios and standard 
errors) were converted into the approximate Bayes factors using the Wakefield approach 87. 
A cis-regulatory region of 1Mb centred at the transcription start site (TSS) was defined for 
each gene (Ensembl GRCh37 Release 101). The Bayes factors of variants existing in each 
cis region were weighted and averaged by the prior probability (an exponential function of 
TSS proximity) estimated from the distance distribution of regulatory interactions 88. The 
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likelihood of an fGWAS model was given by the averaged Bayes factors across all genome-
wide genes multiplied by the feature-level prior probability obtained from a linear 
combination of cell type specific expression and the averaged expression across all cell 
types as a baseline expression. The enrichment of each cell type was estimated as the 
maximum likelihood estimator of the effect size for the cell type specific expression. The 
code of the pairwise hierarchical model (see URL: https://github.com/natsuhiko/PHM) was 
utilised for the enrichment analysis. The detailed model derivation is demonstrated in the 
Supplementary Note Section 1. 
 
Cryosectioning, smFISH, and confocal imaging 
Fetal gut tissue was embedded in optimal cutting temperature medium (OCT) and frozen on 
an isopentane-dry ice slurry at -60°C, and then cryosectioned onto SuperFrost Plus slides at 
a thickness of 10 μm. Prior to staining, tissue sections were post-fixed in 4% 
paraformaldehyde in PBS for 15 minutes at 4°C, then dehydrated through a series of 50%, 
70%, 100%, and 100% ethanol, for 5 minutes each. Staining with the RNAscope Multiplex 
Fluorescent Reagent Kit v2 Assay (Advanced Cell Diagnostics, Bio-Techne) was automated 
using a Leica BOND RX, according to the manufacturers’ instructions. Following manual pre-
treatment, automated processing included epitope retrieval by protease digestion with 
Protease IV for 30 minutes prior to RNAscope probe hybridisation and channel development 
with Opal 520, Opal 570, and Opal 650 dyes (Akoya Biosciences). Stained sections were 
imaged with a Perkin Elmer Opera Phenix High-Content Screening System, in confocal 
mode with 1 μm z-step size, using a 20× water-immersion objective (NA 0.16, 0.299 
μm/pixel). Channels: DAPI (excitation 375 nm, emission 435-480 nm), Opal 520 (ex. 488 
nm, em. 500-550 nm), Opal 570 (ex. 561 nm, em. 570-630 nm), Opal 650 (ex. 640 nm, em. 
650-760 nm). 
 
Flow cytometry validation of Fcgr on mice tuft cells 
Small intestines from C57BL/6 mice were flushed of faecal content with ice-cold PBS, 
opened longitudinally, cut into 0.5 cm pieces, and washed by vortexing three times with PBS 
with 10mM HEPES. Tissue was then incubated with an epithelial stripping solution (RPMI-
1640 with 2% (v/v) FCS, 10mM HEPES, 1mM DTT, and 5 mM EDTA) at 37°C for two 
intervals of 20 minutes to remove epithelial cells. The epithelial fraction was subsequently 
incubated at 37°C for 10 minutes with dispase (0.3 U/mL, Sigma-Aldrich) and passed 
through a 100µm filter to obtain a single-cell suspension. Cells were blocked for 20 minutes 
at 4°C with 0.5% (v/v) heat-inactivated mouse serum followed by extracellular staining in 
PBS at 4°C for 45 minutes with the following antibodies; EpCAM-FITC (1:400, G8.8, 
Invitrogen), CD45-Bv650 (1:200, 30-F11, BioLegend), CD11b-Bv421 (1:300, M1/70, BD 
Biosciences), Siglec-F-APC (1:200, 1RNM44N, Invitrogen), FcγRI-PE (1:200, X54-5/7.1, 
BioLegend), FcγRIIB-PE (1:200, AT130-2, Invitrogen), FcγRII/RIII-PE (1:200, 2.4G2, BD 
Biosciences), FcγRIV-PE (1:200, 9E9, BioLegend) and Rat IgG2b, κ isotype-PE-Cy7 (1:200, 
LOU/C, BD Biosciences). Cells were then stained with LIVE/DEAD Fixable Aqua Dead Cell 
Stain Kit (Thermo Fisher Scientific) for 20 minutes at room temperature, fixed with 2% PFA, 
and analysed on a CytoFLEX LX (Beckman Coulter) flow cytometer. 
 
Data availability  
The expression data for fetal and adult regions is available in an interactive browsing 
website: www.gutcellatlas.org. Raw sequencing data are available at ArrayExpress 
(accession numbers E-MTAB-9543, E-MTAB-9536, E-MTAB-9532 and E-MTAB-9533). 
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